Fingerprint
Dive into the research topics of 'Emerging drugs for the treatment of idiopathic pulmonary fibrosis: 2020 phase II clinical trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Emerging drugs for the treatment of idiopathic pulmonary fibrosis: 2020 phase II clinical trials
Giacomo Sgalla, Marialessia Lerede, Luca Richeldi
Research output: Contribution to journal › Editorial